Clinical Trial Update: Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating temozolomide followed by radiation therapy in children with newly diagnosed malignant CNS tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Neoplasms
• Neuroblastoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Duke University | Conditions: Brain and Central Nervous System Tumors, Neuroblastoma | Phase 2 | Status: COMPLETED